Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 26Glioblastoma 25Gliosarcoma 22Rhabdomyosarcoma 21Sarcoma, Ewing 18Glioma 15Brain Neoplasms 14Astrocytoma 13Neuroblastoma 12Central Nervous System Neoplasms 12Oligodendroglioma 9Osteosarcoma 8Neoplasms 7Medulloblastoma 6Pancreatic Neoplasms 5Neuroectodermal Tumors, Primitive, Peripheral 5Neoplasm Metastasis 5Breast Neoplasms 5Colorectal Neoplasms 4Bone Neoplasms 4Stomach Neoplasms 3Recurrence 3Optic Nerve Glioma 3Malignant mesenchymal tumor 3Diffuse Intrinsic Pontine Glioma 3Colonic Neoplasms 3Wilms Tumor 2Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Rhabdoid Tumor 2

Interventions

sargramostim 1indolepropanol phosphate 1Vincristine 1Tirapazamine 1Pharmacogenomic Testing 1Irinotecan 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Alveolar Childhood Rhabdomyosarcoma × Irinotecan × Sarcoma × Clear all
NCT00025363 2013-01-17

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
150 enrolled
Sarcoma

Alveolar Childhood Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡